CROMA Saypha® Filler Lidocaine 1x1 ml – Cross-Linked Hyaluronic Acid Dermal Filler for Natural Volume Restoration
 
CROMA Saypha® Filler Lidocaine 1x1 ml is a high-quality cross-linked hyaluronic acid dermal filler developed by CROMA-Pharma GmbH (Austria).
It is specifically designed to correct moderate to deep facial wrinkles, restore volume, and enhance facial contours while maintaining a natural and balanced appearance.
The inclusion of 0.3% lidocaine ensures a more comfortable injection experience for both the patient and practitioner.
 
Product Overview
Part of the CROMA Saypha® line, this filler combines precision, safety, and long-lasting aesthetic results.
It is ideal for facial contouring and wrinkle correction in patients seeking natural rejuvenation without excessive volume.
 
Technology & Composition
Technology: Patented S.M.A.R.T. cross-linking process – ensuring optimal elasticity, durability, and tissue integration.
Composition:
• Cross-linked Hyaluronic Acid (20 mg/ml) – provides structure, hydration, and volume.
• Lidocaine Hydrochloride (0.3%) – enhances patient comfort by reducing injection pain.
• Phosphate Buffer, pH 7.1 – maintains stability and biocompatibility.
Packaging (Content):
• 1 prefilled sterile syringe of 1 ml
• 2 sterile 27G ½” needles
• Instruction leaflet and traceability labels
• For single-patient use only
 
Indications & Treatment Areas
Designed for the correction of moderate to deep facial wrinkles and folds, as well as contouring and volume restoration.
 
Recommended Treatment Areas:
Nasolabial folds
Marionette lines
Cheeks (for volumization)
Chin
Jawline
 
Clinical Benefits
Restores natural volume in facial areas affected by aging
Smooths wrinkles and folds with precision
Provides natural-looking results with excellent tissue integration
Comfortable injection experience thanks to lidocaine
Long-lasting effects, maintaining hydration and structure for up to 12 months
 
Treatment Protocol
Application: Inject slowly into the mid to deep dermis using linear or serial puncture technique.
Sessions: Typically one treatment session; touch-ups may be scheduled after 2–4 weeks if necessary.
Duration of results: Typically 6–12 months, depending on area treated, injection depth, and individual metabolism.
 
Manufacturer & Regulatory Information
Manufactured by CROMA-Pharma GmbH (Austria).
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745.
ISO 13485 certified manufacturer.
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union.
 
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety and patient care.